Clinical Trial Update: Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluates how patients perceive treatment outcomes with darifenacin for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Darifenacin (darifenacin)

Snippet

Sponsor: Novartis | Conditions: Overactive Bladder (OAB) | Phase 4 | Status: COMPLETED